<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ganesan R</submitter><funding>American Heart Association</funding><funding>NHLBI NIH HHS</funding><funding>National Institutes of Health</funding><funding>NIGMS NIH HHS</funding><pagination>15888-15906</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7686130</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>34(12)</volume><pubmed_abstract>A successful acute inflammatory response results in the elimination of infectious agents by neutrophils and monocytes, followed by resolution and repair through tissue-resident and recruited macrophages. Resolvins (D-series and E-series) are pro-resolving lipid mediators involved in resolution and tissue repair, whose intracellular signaling remains of interest. Here, we report that D-series resolvins (RvD1- RvD5) activate phospholipase D (PLD), a ubiquitously expressed membrane lipase enzyme activity in modulating phagocyte functions. The mechanism for PLD-mediated actions of Resolvin-D5 (RvD5) in polarizing macrophages (M1-like toward M2-like) was found to be two-pronged: (a) RvD5 inhibits post-transcriptional modifications, by miRs and 3'exonucleases that process PLD2 mRNA, thus increas</pubmed_abstract><journal>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</journal><pubmed_title>D-series Resolvins activate Phospholipase D in phagocytes during inflammation and resolution.</pubmed_title><pmcid>PMC7686130</pmcid><funding_grant_id>R01 HL056653</funding_grant_id><funding_grant_id>P01 GM095467</funding_grant_id><funding_grant_id>13GRNT17230097</funding_grant_id><funding_grant_id>R29 HL056653</funding_grant_id><funding_grant_id>P01GM095467</funding_grant_id><funding_grant_id>HL056653‐14</funding_grant_id><pubmed_authors>Henkels KM</pubmed_authors><pubmed_authors>Ganesan R</pubmed_authors><pubmed_authors>Cheemarla NR</pubmed_authors><pubmed_authors>Gomez-Cambronero J</pubmed_authors><pubmed_authors>Serhan CN</pubmed_authors><pubmed_authors>De La Rosa X</pubmed_authors><pubmed_authors>Libreros S</pubmed_authors><pubmed_authors>Shah K</pubmed_authors></additional><is_claimable>false</is_claimable><name>D-series Resolvins activate Phospholipase D in phagocytes during inflammation and resolution.</name><description>A successful acute inflammatory response results in the elimination of infectious agents by neutrophils and monocytes, followed by resolution and repair through tissue-resident and recruited macrophages. Resolvins (D-series and E-series) are pro-resolving lipid mediators involved in resolution and tissue repair, whose intracellular signaling remains of interest. Here, we report that D-series resolvins (RvD1- RvD5) activate phospholipase D (PLD), a ubiquitously expressed membrane lipase enzyme activity in modulating phagocyte functions. The mechanism for PLD-mediated actions of Resolvin-D5 (RvD5) in polarizing macrophages (M1-like toward M2-like) was found to be two-pronged: (a) RvD5 inhibits post-transcriptional modifications, by miRs and 3'exonucleases that process PLD2 mRNA, thus increas</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Dec</publication><modification>2025-04-21T21:42:42.429Z</modification><creation>2022-02-11T13:14:40.918Z</creation></dates><accession>S-EPMC7686130</accession><cross_references><pubmed>33047359</pubmed><doi>10.1096/fj.201903025RR</doi><doi>10.1096/fj.201903025rr</doi></cross_references></HashMap>